Literature DB >> 24746273

Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model.

Vikhyat S Bebarta1, David A Tanen2, Susan Boudreau3, Maria Castaneda3, Lee A Zarzabal3, Toni Vargas3, Gerry R Boss4.   

Abstract

STUDY
OBJECTIVE: Hydroxocobalamin is a Food and Drug Administration-approved antidote for cyanide poisoning. Cobinamide is a potential antidote that contains 2 cyanide-binding sites. To our knowledge, no study has directly compared hydroxocobalamin with cobinamide in a severe, cyanide-toxic large-animal model. Our objective is to compare the time to return of spontaneous breathing in swine with acute cyanide-induced apnea treated with intravenous hydroxocobalamin, intravenous cobinamide, or saline solution (control).
METHODS: Thirty-three swine (45 to 55 kg) were intubated, anesthetized, and instrumented (continuous mean arterial pressure and cardiac output monitoring). Anesthesia was adjusted to allow spontaneous breathing with FiO2 of 21% during the experiment. Cyanide was continuously infused intravenously until apnea occurred and lasted for 1 minute (time zero). Animals were then randomly assigned to receive intravenous hydroxocobalamin (65 mg/kg), cobinamide (12.5 mg/kg), or saline solution and monitored for 60 minutes. A sample size of 11 animals per group was selected according to obtaining a power of 80%, an α of .05, and an SD of 0.17 in mean time to detect a 20% difference in time to spontaneous breathing. We assessed differences in time to death among groups, using Kaplan-Meier estimation methods, and compared serum lactate, blood pH, cardiac output, mean arterial pressure, respiratory rate, and minute ventilation time curves with repeated-measures ANOVA.
RESULTS: Baseline weights and vital signs were similar among groups. The time to apnea and cyanide dose required to achieve apnea were similar. At time zero, mean cyanide blood and lactate concentrations and reduction in mean arterial pressure from baseline were similar. In the saline solution group, 2 of 11 animals survived compared with 10 of 11 in the hydroxocobalamin and cobinamide groups (P<.001 between the 2 treated groups and the saline solution group). Time to return of spontaneous breathing after antidote was similar between hydroxocobalamin and cobinamide (1 minute 48 seconds versus 1 minute 49 seconds, respectively). Blood cyanide concentrations became undetectable at the end of the study in both antidote-treated groups, and no statistically significant differences were detected between the 2 groups for mean arterial pressure, cardiac output, respiratory rate, lactate, or pH.
CONCLUSION: Both hydroxocobalamin and cobinamide rescued severely cyanide-poisoned swine from apnea in the absence of assisted ventilation. The dose of cobinamide was one fifth that of hydroxocobalamin.
Copyright © 2014 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24746273      PMCID: PMC4487531          DOI: 10.1016/j.annemergmed.2014.02.009

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  16 in total

1.  A reproducible nonlethal animal model for studying cyanide poisoning.

Authors:  J Vick; M T Marino; J D von Bredow; A Kaminskis; T Brewer
Journal:  Mil Med       Date:  2000-12       Impact factor: 1.437

2.  Cyanide detoxification by the cobalamin precursor cobinamide.

Authors:  Kate E Broderick; Prasanth Potluri; Shunhui Zhuang; Immo E Scheffler; Vijay S Sharma; Renate B Pilz; Gerry R Boss
Journal:  Exp Biol Med (Maywood)       Date:  2006-05

3.  The CounterACT Research Network: basic mechanisms and practical applications.

Authors:  David A Jett; David T Yeung
Journal:  Proc Am Thorac Soc       Date:  2010-07

Review 4.  Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a task force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Writing Group.

Authors:  A H Idris; L B Becker; J P Ornato; J R Hedges; N G Bircher; N C Chandra; R O Cummins; W Dick; U Ebmeyer; H R Halperin; M F Hazinski; R E Kerber; K B Kern; P Safar; P A Steen; M M Swindle; J E Tsitlik; I von Planta; M von Planta; R L Wears; M H Weil
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

5.  Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring.

Authors:  Matthew Brenner; Sari B Mahon; Jangwoen Lee; Jae Kim; David Mukai; Seth Goodman; Kelly A Kreuter; Rebecca Ahdout; Othman Mohammad; Vijay S Sharma; William Blackledge; Gerry R Boss
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

Review 6.  Hydroxocobalamin in cyanide poisoning.

Authors:  John P Thompson; Timothy C Marrs
Journal:  Clin Toxicol (Phila)       Date:  2012-11-19       Impact factor: 4.467

7.  Cobinamide is superior to other treatments in a mouse model of cyanide poisoning.

Authors:  Adriano Chan; Maheswari Balasubramanian; William Blackledge; Othman M Mohammad; Luis Alvarez; Gerry R Boss; Timothy D Bigby
Journal:  Clin Toxicol (Phila)       Date:  2010-08       Impact factor: 4.467

8.  Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.

Authors:  Stephen W Borron; Frédéric J Baud; Patrick Barriot; Michel Imbert; Chantal Bismuth
Journal:  Ann Emerg Med       Date:  2007-05-04       Impact factor: 5.721

9.  Intramuscular cobinamide sulfite in a rabbit model of sublethal cyanide toxicity.

Authors:  Matthew Brenner; Jae G Kim; Sari B Mahon; Jangwoen Lee; Kelly A Kreuter; William Blackledge; David Mukai; Steve Patterson; Othman Mohammad; Vijay S Sharma; Gerry R Boss
Journal:  Ann Emerg Med       Date:  2010-01-04       Impact factor: 5.721

10.  The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide.

Authors:  Kate E Broderick; Maheswari Balasubramanian; Adriano Chan; Prasanth Potluri; Jake Feala; Darrell D Belke; Andrew McCulloch; Vijay S Sharma; Renate B Pilz; Timothy D Bigby; Gerry R Boss
Journal:  Exp Biol Med (Maywood)       Date:  2007-06
View more
  15 in total

1.  The Vitamin B12 Analog Cobinamide Is an Effective Antidote for Oral Cyanide Poisoning.

Authors:  Jangwoen Lee; Sari B Mahon; David Mukai; Tanya Burney; Behdod S Katebian; Adriano Chan; Vikhyat S Bebarta; David Yoon; Gerry R Boss; Matthew Brenner
Journal:  J Med Toxicol       Date:  2016-09-15

2.  Sodium Nitrite and Sodium Thiosulfate Are Effective Against Acute Cyanide Poisoning When Administered by Intramuscular Injection.

Authors:  Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss
Journal:  Ann Emerg Med       Date:  2016-12-29       Impact factor: 5.721

3.  Case Files from the University of California San Diego Health System Fellowship Coma and Severe Acidosis: Remember to Consider Acetaminophen.

Authors:  Janna H Villano; Charles W O'Connell; Binh T Ly; Aaron Schneir
Journal:  J Med Toxicol       Date:  2015-09

4.  Cyanide Scavenging by a Cobalt Schiff-Base Macrocycle: A Cost-Effective Alternative to Corrinoids.

Authors:  Elisenda Lopez-Manzano; Andrea A Cronican; Kristin L Frawley; Jim Peterson; Linda L Pearce
Journal:  Chem Res Toxicol       Date:  2016-05-26       Impact factor: 3.739

Review 5.  Past, present and future of cyanide antagonism research: From the early remedies to the current therapies.

Authors:  Ilona Petrikovics; Marianna Budai; Kristof Kovacs; David E Thompson
Journal:  World J Methodol       Date:  2015-06-26

6.  Nitrocobinamide, a new cyanide antidote that can be administered by intramuscular injection.

Authors:  Adriano Chan; Jingjing Jiang; Alla Fridman; Ling T Guo; G Diane Shelton; Ming-Tao Liu; Carol Green; Kristofer J Haushalter; Hemal H Patel; Jangwoen Lee; David Yoon; Tanya Burney; David Mukai; Sari B Mahon; Matthew Brenner; Renate B Pilz; Gerry R Boss
Journal:  J Med Chem       Date:  2015-02-16       Impact factor: 7.446

7.  Pilot Trial of Intravenous Lipid Emulsion Treatment for Severe Nifedipine-Induced Shock.

Authors:  Christine M Murphy; Cliff Williams; Michael E Quinn; Brian Nicholson; Thomas Shoe; Michael C Beuhler; William P Kerns
Journal:  J Med Toxicol       Date:  2016-08-08

8.  Intramuscular dimethyl trisulfide: efficacy in a large swine model of acute severe cyanide toxicity.

Authors:  Tara B Hendry-Hofer; Alyssa E Witeof; Dennean S Lippner; Patrick C Ng; Sari B Mahon; Matthew Brenner; Gary A Rockwood; Vikhyat S Bebarta
Journal:  Clin Toxicol (Phila)       Date:  2018-10-11       Impact factor: 4.467

9.  Circulatory Failure During Noninhaled Forms of Cyanide Intoxication.

Authors:  Philippe Haouzi; Nicole Tubbs; Matthew D Rannals; Annick Judenherc-Haouzi; Larry A Cabell; Joe A McDonough; Takashi Sonobe
Journal:  Shock       Date:  2017-03       Impact factor: 3.454

10.  Characterization of a Swine (Sus scrofa) Model of Oral Potassium Cyanide Intoxication.

Authors:  Patrick C Ng; Tara B Hendry-Hofer; Alyssa E Witeof; Matthew Brenner; Sari B Mahon; Gerry R Boss; Vikhyat S Bebarta
Journal:  Comp Med       Date:  2018-09-12       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.